478
Participants
Start Date
September 9, 2015
Primary Completion Date
June 15, 2017
Study Completion Date
January 7, 2019
Carfilzomib
Carfilzomib was administered as an IV infusion
Dexamethasone
Commercially available dexamethasone was obtained by the investigational site.
Research Site, Brussels
Research Site, Budapest
Research Site, Brussels
Research Site, Otahuhu, Auckland
Research Site, Darlinghurst
Research Site, Antwerp
Research Site, Copenhagen
Research Site, Waratah
Research Site, Tweed Heads
Research Site, Leuven
Research Site, Box Hill
Research Site, Debrecen
Research Site, Odense C
Research Site, Gyula
Research Site, Trondheim
Research Site, Vejle
Research Site, Kaposvár
Research Site, Bruges
Research Site, Christchurch
Research Site, Ghent
Research Site, Aalborg
Research Site, New York
Research Site, Torino
Research Site, Athens
Research Site, Athens
Research Site, Pittsburgh
Research Site, Genova
Research Site, Girona
Research Site, Rostock
Research Site, Turku
Research Site, Bethesda
Research Site, Rockville
Research Site, Dijon
Research Site, Brescia
Research Site, Pátrai
Research Site, Pavia
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Piacenza
Research Site, Brest
Research Site, Nîmes
Research Site, Pamplona
Research Site, Tampere
Research Site, Rennes
Research Site, Salamanca
Research Site, Tours
Research Site, Bologna
Research Site, Seville
Research Site, Nantes
Research Site, Zaragoza
Research Site, Florence
Research Site, Cologne
Research Site, Pisa
Research Site, Ancona
Research Site, Bayonne
Research Site, Pierre-Bénite
Research Site, Tübingen
Research Site, Paris
Research Site, Tyler
Research Site, Napoli
Research Site, München
Research Site, Catania
Research Site, Brasov
Research Site, Scottsdale
Mayo Clinic, Scottsdale
Center for Cancer and Blood Disorders, Bethesda
Maryland Oncology Hematology, P.A, Rockville
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Blood and Cancer Center of East Texas, Tyler
Research Site, Hackensack
Research Site, Calgary
Research Site, Kelowna
Research Site, Vancouver
Research Site, St. John's
Research Site, Halifax
Research Site, Ottawa
Research Site, Toronto
Research Site, Montreal
Research Site, Québec
Research Site, Brno
Research Site, Hradec Králové
Research Site, Olomouc
Research Site, Ostrava-Poruba
Research Site, Prague
Research Site, Prague
Research Site, Helsinki
Research Site, Leipzig
Research Site, Cagliari
Research Site, Roma
Research Site, Roma
Research Site, Toyohashi
Research Site, Fukuoka
Research Site, Ogaki-shi
Research Site, Maebashi
Research Site, Shibukawa-shi
Research Site, Sapporo
Research Site, Isehara-shi
Research Site, Kyoto
Research Site, Sendai
Research Site, Okayama
Research Site, Suita-shi
Research Site, Kawagoe-shi
Research Site, Utsunomiya
Research Site, Chuo-ku
Research Site, Koto-ku
Research Site, Shibuya-ku
Research Site, Tachikawa-shi
Research Site, Fukuoka
Research Site, Nagoya
Research Site, Niigata
Research Site, Tokushima
Research Site, Oslo
Research Site, Brzozów
Research Site, Chorzów
Research Site, Katowice
Research Site, Krakow
Research Site, Lodz
Research Site, Olsztyn
Research Site, Poznan
Research Site, Torun
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Bucharest
Research Site, Palma de Mallorca
Research Site, Badalona
Research Site, Barcelona
Research Site, Gothenburg
Research Site, Helsingborg
Research Site, Lund
Research Site, Stockholm
Research Site, Stockholm
Research Site, Uddevalla
Research Site, Bournemouth
Research Site, London
Research Site, London
Research Site, Manchester
Research Site, Nottingham
Research Site, Sheffield
Research Site, Wolverhampton
Lead Sponsor
Amgen
INDUSTRY